Drug Delivery and Targeting
03 June 2012 - 05 June 2012
The conference is dedicated to the drug solubility, solubilization, nanoparticles and drug targeting. The three-day conference will consist of four plenary lectures, a number of shorter oral presentations as well as poster presentations. There will be a preconference workshop on June 2nd where toxicological and regulatory issues of new pharmaceutical excipients will be discussed by representatives from both the industry and government agencies. In this workshop the emphasis will be on cyclodextrins and cyclodextrin derivatives.
Icelandair Hotel Reykjavik Natura
https://crsnordic2012.hi.is/Welcome.html
6th Drug Design & Medicinal Chemistry
07 June 2012 - 08 June 2012
Experts will facilitate discourse on topics such as strategies for hit and target identification, fragment based drug design, chemoinformatics, protein-protein interactions, ligand based drug design, computer aided drug design, protein flexibility, high performance computing, covalent inhibitors, mutational resistance, selectivity of kinase inhibitors, potency, specificity, lead optimization, ADMET, safety in drug discovery, advances in drug delivery and much more.
Hilton San Diego Resort & Spa, San Diego, CA, USA
http://www.gtcbio.com/index.php?option=com_conference&file=home&cn=6th%20Drug%20Design%20&cid=46
Antibody Design and Discovery
07 June 2012 - 08 June 2012
We’ll explore novel technologies being utilized to identify and select antibodies with better accuracy and efficiency, and learn about new optimization and developability techniques to enhance effective function. Moreover, attendees will hear directly from scientists and researchers about emerging clinical data, and its implications for the advancement of the field, including therapeutic antibodies in cancer, and infectious and autoimmune diseases.
Hilton San Diego Resort & Spa, San Diego, CA, USA
http://www.gtcbio.com/index.php?option=com_conference&file=home&cn=Antibody%20Design%20and%20Discovery&cid=84
RNAi & Nanotechnology
11 June 2012 - 12 June 2012
The event will provide a complete picture of developments in the RNAi field, focusing on siRNA Development, Nano-enabled Nucleic Acid Delivery as well asas technological, regulatory and intellectual property updates and will be the ideal opportunity for problem-solving discussion and idea-sharing debate.
Copthorne Tara Hotel, Central London, UK
http://www.smi-online.co.uk/events/overview.asp?is=4&ref=3913
13th Annual Drug Discovery Leaders Summit
11 June 2012 - 12 June 2012
Oxford Global Conferences are pleased to announce the 13th Annual Drug Discovery Leaders Summit being held in June 2012 in Switzerland. The event offers over 250 attendees a valuable opportunity to network with senior-level decision-makers from leading pharmaceutical, biotech companies, clinical research institutions, academic and healthcare institutions working throughout the Drug Discovery & Development Value Chain. The event is also co-located with 4th Annual Drug Development Summit.
Renaissance Tower Hotel Zurich, Switzerland
http://www.drugdiscovery-summit.com/
Practical Aspects of Small Molecule Drug Discovery: At the interface of biology, chemistry and pharmacology
17 June 2012 - 22 June 2012
This residential course aims to give researchers of any discipline a broad introduction to the theoretical, practical and organisational aspects of small molecule drug discovery. Each topic will include a lecture together with discussion sessions or case histories to develop key aspects highlighted in the lectures. In addition there will be practical sessions to illustrate the beginnings of drug discovery programmes, including the production of target product profiles, project plans and milestones, compound progression criteria and scientific strategy.
Wellcome Trust Genome Campus, Hinxton, Cambridge, UK
http://www.wellcome.ac.uk/Education-resources/Courses-and-conferences/Advanced-Courses-and-Scientific-Conferences/Advanced-Courses/WTX041285.htm